SCHEMBL7147995

SCHEMBL7147995

CC(C)(C)OC(=O)Nc1cc(COC2CCCCO2)c(C#Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HCAR3 P49019 2/20 0.35
CREBBP Q92793 2/20 0.35
EP300 Q09472 1/20 0.35
MAPT P10636 4/20 0.34
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD5 P21918 1/20 0.33
DRD3 P35462 1/20 0.33
P2RY6 Q15077 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145150 0.92 ADRA2A (0.35) ALDH1A1L3MBTL1HCAR3CREBBPMAPT
SCHEMBL7139841 0.87 HDAC3 (0.38) CREBBPEP300MEN1KMT2A
SCHEMBL7139782 0.87 MEN1 (0.36) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL7146883 0.82 NPC1 (0.36) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7140551 0.82 HCAR3 (0.36) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL7148597 0.82 MMP2 (0.38) ALDH1A1NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL6167226 0.82 NPC1 (0.38) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL7139514 0.82 CHRM3 (0.35) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2
SCHEMBL5563454 0.81 KMT2A (0.38) ALDH1A1L3MBTL1SMN1; SMN2HCAR3CREBBP
SCHEMBL7142233 0.81 PDGFRB (0.37) ALDH1A1L3MBTL1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed